medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 2

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (2)

Percutaneous coronary intervention in women with ischemic heart disease. Hospital ''Hermanos Ameijeiras''

Luperon LD, Enrique VSJ, Rodríguez BS, Quesada PS, Blanco PY, Jarque VVM

Language: Spanish
References: 50
Page:
PDF size: 413.12 Kb.


ABSTRACT

Introduction: Cardiovascular diseases are the most frequent cause of death in women; these can be treated by precutaneous intervention. Objective: To describe the results of percutaneous coronary intervention in women. Material and method: A cross-sectional descriptive observational study was carried out in women treated at the Hemodynamics service of the HermanosAmeijeiras Clinical Surgical Hospital between January 2013 and December 2017. Results: The mean age was 62.75 ± 13.98 years; 348 cases (76.5%) had high blood pressure as a risk factor. The diagnosis was stable angina in 244 cases (53.6%), 247 patients (54.3%) had disease of one vessel, in 57.8% the anterior descending artery was treated and in 47% a type B1 lesion was treated. The most used access was the radial route (367 cases; 80.7%). In 322 cases (50.9%) the direct stent was not placed and it was of the conventional type in 398 (62.9%). The technical result was successful in 439 patients (96.5%). Only 24 (5.3%) complications were observed. Conclusions: In the patients studied, the majority of the elderly and with stable angina, one-vessel disease and type B1 lesion were the most represented. The non-direct stent technique was the most widely used to treat coronary stenosis, as well as the conventional stent. The technical result of the percutaneous coronary intervention was successful, with a low frequency of complications.


REFERENCES

  1. Heras M. Cardiopatía isquémica en la mujer: presentación clínica, pruebas diagnósticas y tratamiento de los síndromes coronarios agudos. RevEspCardiol. [Internet]. 2006 [citado 23 Ene 2021]; 59(4):371-81. Disponible en: https://www.revespcardiol.org/es-content-articulo-13087060

  2. Ferraz Torres M, Marín Fernández B, Belzunegui Otano T. Factores relacionados a las desigualdades de género observadas en el tratamiento de la cardiopatía isquémica en los servicios de urgencias. Revista científica e informativa de la Asociación Española de Enfermería en Cardiología [Internet]. 2016 [citado 23 Ene 2021], 68: 54-59. Disponible en https://dialnet.unirioja.es/servlet/articulo?codigo=6282049

  3. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J [Internet]. 2014 [cited 2021 Jan 25]; 35(42):2950-9. Available from: https://academic.oup.com/eurheartj/article-abstract/35/42/2950/2293157

  4. Gallego Curto E. Mujer y cardiopatía aguda: estudio descriptivo del perfil antropométrico y clínico en una región objetivo uno de la Unión Europea [Tesis]. Madrid: Universidad Complutense Madrid; 2018. Disponible en: https://eprints.ucm.es/46933/1/T39738.pdf

  5. Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J [Internet]. 2016 [cited 2021 Jan 23]; 37:24-34. Available from: https://academic.oup.com/eurheartj/article/37/1/24/2398374

  6. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2017. Dirección Nacional de Estadísticas. La Habana: MINSAP; 2018.

  7. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J GendSpecif Med [Internet]. 2002 [cited 2021 Jan 25]; 5(2):27-37. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11974672

  8. Sweitzer NK, Douglas PS. Cardiovascular disease in women. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwalds Heart Diseases. A textbook of cardiovascular medicine. Philadelphia: Elsevier Saunders; 2015.p. 1951-64.

  9. Kosova E, Ricciardi M. Cardiac Catheterization. JAMA [Internet]. 2017 [cited 2021 Jan 25]; 317(22):2344. Available from: https://jamanetwork.com/journals/jama/article-abstract/2631532

  10. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the european society of cardiology. Eur Heart J [Internet]. 2005 [cited 2021 Jan 25]; 26(8):804-47. Available from: https://academic.oup.com/eurheartj/article/26/8/804/2888081

  11. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med [Internet]. 1987 [cited 2021 Jan 25]; 316(12):701-6. Available from: https://www.jvascsurg.org/article/0741-5214(87)90320-X/pdf

  12. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med [Internet]. 2013 [cited 2021 Jan 25]; 368(3):254-65. Available from: https://www.nejm.org/doi/full/10.1056/NEJMra1210816

  13. World Health Organization (WHO) Tobacco: deadly in any form of disguise. World non tobacco day Geneva, Switzeland WHO [Internet] 2006 [cited 2021 Jan 25]. Available from: https://apps.who.int/iris/bitstream/handle/10665/43465/9241563222_eng.pdf

  14. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. Ministerio de Salud Pública de Cuba. Guía Cubana de Diagnóstico, Evaluación y Tratamiento de la Hipertensión Arterial. Rev Cubana Med [Internet]. 2017 [citado 25 Ene 2021];56(Suplemento Especial):[aprox. 85p]. Disponible en:http://bvs.sld.cu/revistas/med/vol56_sup_17/sumario.htm)

  15. Royo Bordonada MA, Lobos Bejarano JM, Millán Núñez-Cortés J, Villar Álvarez F, Brotons Cuixart C, Camafort Babkowski M, Guijarro Herráiz C, de Pablo Zarzosa C, Botet Montoya JP, de Santiago Nocito AM. Dislipidemias: un reto pendiente en prevención cardiovascular. Documento de consenso CEIPC/SEA. Medicina Clínica [Internet]. 2011 [citado 25 Ene 2021];137(1): 30.e1-30.e13. Disponible en: https://doi.org/10.1016/j.medcli.2011.02.008

  16. Corbatón Anchuelo A, Cuervo Pinto R, Serrano Ríos M. Diabetes mellitus. Concepto, clasificación y mecanismos etiopatogénicos. Medicina-Programa de formación médica continuada [Internet]. 2004 [citado 25 Ene 2021];9(16): 963-970. Disponible en: https://doi.org/10.1016/S0211-3449(04)70144-7

  17. Moreno M. Definición y clasificación de la obesidad. Revista Médica Clínica las Condes [Internet]. 2012 [citado 25 Ene 2021];23(2): 124-128. Disponible en: https://doi.org/10.1016/S0716-8640(12)70288-2

  18. Jean-Philippe Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronay syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal [Internet] 2020 [cited 2021 Jan 25], 1_79 ESC GUIDELINES. Available from: doi: 10.1093/eurheartj/ehaa575

  19. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patients selection. Circulation [Internet]. 1990 [cited 2021 Jan 25]; 82: 1193-1202. Available from: https://www.ahajournals.org/doi/abs/10.1161/01.cir.82.4.1193

  20. Smolina K, Ball L, Humphries KH, Khan N, Morgan SG. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women. CircCardiovascQual Outcomes [Internet]. 2015 [cited 2021 Jan 25]; 8(6):586-92. Available from: https://www.ahajournals.org/doi/full/10.1161/circoutcomes.115.001987

  21. Kytö V, Sipilä J, Rautava P. Gender and in-hospital mortality of ST-segment elevation myocardial infarction (from a multihospital nationwide registry study of 31,689 patients). Am J Cardiol [Internet]. 2015 [cited 2021 Jan 25]; 115(3):303-6. Available from: https://www.sciencedirect.com/science/article/pii/S0002914914020694

  22. Costabel JP, Burgos LM, Cigalini IM ,García S, Duczynsk MP, Giordanino EF, et al . Infarto de miocardio con supradesnivel del segmento ST en mujeres en Argentina. Subanálisis del registro CONAREC XVII. Rev Argent Cardiol [Internet]. 2017 [citado 25 Ene 2021]; 85:435-43. Availablefrom: https://www.sac.org.ar/wp-content/uploads/2018/03/v85n5a05.pdf

  23. Brieger D, Hyun K, Chew D, Amerena J, Farouque O, MacIsaac A, et al. The relationship between the proportion of admitted high risk ACS patients and hospital delivery of evidence based care. Int J Cardiol [Internet]. 2016 [cited 2021 Jan 25]; 222:86-92. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0167527316314140

  24. Worrall L, McEvedy S, Wilson A, Rahman MA. Gender Differences in presentation, coronary intervention, and outcomes of 28 985 acute coronary syndrome patients in Victoria, Australia. Womens Health Issues [Internet]. 2016 [cited 2021 Jan 25]; 26(1):14-20. Available from: https://doi.org/10.1016/j.whi.2015.09.002

  25. Centro de Estudios de Población y Desarrollo. Oficina Nacional de Estadística e Información. El Color de la Piel según el Censo de Población y Viviendas de 2012. República de Cuba. La Habana; 2016.

  26. Marcheco Teruel B, Parra EJ, Fuentes Smith E, Salas A, Buttenschøn HN, et al. Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers. PLoS Genet [Internet] 2014 [cited 2021 Jan 25]; 10(7):e1004488. Available from: https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004488

  27. Coronado BE, Griffith JL, Beshansky JR, Selker HP. Hospital mortality in women and men with acute cardiac ischemia: a prospective multicenter study. J Am CollCardiol [Internet]. 1997 [cited 2021 Jan 25]; 29(7):1490-6. Available from: DOI: 10.1016/S0735-1097(97)00077-6

  28. Sauza Sosa JC, Cuéllar Álvarez J, Villegas Herrera KM, Sierra Galán LM. Aspectos clínicos actuales del monitoreo ambulatorio de presión arterial. Arch. Cardiol [Internet]. Méx. [Internet]. 2016 Sep. [citado 25 Ene 2021]; 86 (3):255-259. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-99402016000300255&lng=es. Available from: https://doi.org/10.1016/j.acmx.2015.12.004.

  29. Foussas S. Acute coronary syndromes and diabetes mellitus. Hellenic J Cardiol [Internet]. Sep-Oct 2016 [cited 2021 Jan 25];57(5):375-377. Available from: https://pubmed.ncbi.nlm.nih.gov/28302514/doi: 10.1016/j.hjc.2016.12.012. Epub 2017 Mar 14.

  30. Gina Lundberg, Mary Norine Walsh, Laxmi S Mehta. Sex-Specific Differences in Risk Factors for Development of Heart Failure in Women. [Internet] 2019 Jan [cited 2021 Jan 25];15(1):1-8. Available from: doi: 10.1016/j.hfc.2018.08.001. Epub 2018 Oct 24.

  31. AL Dannenberg, RJ Garrison, WB Kannel Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD 20892. “Incidence of hypertension in the Framingham Study.”, American Journal of Public Health [Internet] 1988 [cited 2021 Jan 25]; 78(1):676-679. Available from: https://doi.org/10.2105/AJPH.78.6.676

  32. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med [Internet]. 1987 [cited 2021 Jan 25]; 317(21):1303-9. Available from: https://www.nejm.org/doi/full/10.1056/NEJM198711193172102

  33. Lewis B, Assmann G, Tikkanen M, Mancini M, Pometta SY. Prevention of coronary heart disease. Scientific Background and New Clinical Guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for the prevention of Coronary Heart Disease. Assmann G. editor. Lipid metabolism disorders and coronary heart disease. 6th ed. Munich: MMV MedizinVerlag; 2013.p. 74-81.

  34. Vaina S, Milkas A, Crysohoou C, Stefanadis C. Coronary artery disease in women: From the yentl syndrome to contemporary treatment. World J Cardiol [Internet]. 2015 [cited 2021 Jan 25]; 7(1):10-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306201/

  35. Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women: A scientific statement from the American Heart Association. Circulation. [Internet]. 2016 [citado 2021 Jan 25]; 133(9):916 47. Available from: https://www.ahajournals.org/doi/abs/10.1161/cir.0000000000000351

  36. Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tideman PA, et al. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart Lung Circ [Internet]. 2016 [cited 2021 Jan 25]; 25(9):895-951. Available from: https://europepmc.org/article/med/28867028

  37. Barreda Pérez AM, López Ferrero L, Rodríguez Nande L, González Espinosa AB, Antuña Aguilar T, Borges Machado L. Caracterización de las mujeres con intervencionismo coronario percutáneo. Rev Cubana CardiolCirCardiovas [Internet]. 2018 [citado 25 Ene 2021]; 24(2). Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/776/html_125

  38. Jarrah MI, Hammoudeh AJ, Al-Natour DB, Khader YS, Tabbalat RA, AlhaddadI A, et al. Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention. Saudi Med J [Internet]. 2017 [cited 2021 Jan 25]; 38(2):149-55. Available from: doi:10.15537/smj.2017.2.16301

  39. Kovacic JC, Mehran R, Karajgikar R, Baber U, Suleman J, Kim MC, et al. Female gender and mortality after percutaneous coronary intervention: Results from a large registry. Catheterization and Cardiovascular Interventions [Internet]. 2012 [cited 2021 Jan 25]; 80:514-21. Available from: https://doi.org/10.1002/ccd.23338

  40. Parra PF, Buitrago N, Carvajal R, Wagner K, Viáfara J, Calle A, et al. Diferencias angiográficas y epidemiológicas entre hombres y mujeres que desarrollan síndrome coronario agudo. RevColombCardiol [Internet]. 2017 [citado 25 Ene 2021]; 24(5):436-41. Disponible en: https://doi.org/10.1016/j.rccar.2017.04.010

  41. Kuhn L, Page K, Rahman MA, Worrall-Carter L. Gender difference in treatment and mortality of patients with ST-segment elevation myocardial infarction admitted to Victorian public hospitals: a retrospective database study. AustCrit Care [Internet]. 2015 [cited 2021 Jan 25]; 28(4):196-202. Available from: https://doi.org/10.1016/j.aucc.2015.01.004

  42. Valero MJ, Velásquez J, Diez F, Devesa C, Juárez M, Sousa I, et al. Sex differences in acute myocardial infarction: Is it only the age? Int J Cardiol [Internet]. 2017 [cited 2021 Jan 25]; 231:36-41. Available from: https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.82.4.1193

  43. Venetsanos D, Sederholm S, Alfredsson J, Janzon M, Cequier A, Chettibi M, et al. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis. BMJ Open [Internet]. 2017 [cited 2021 Jan 25]; 7(9):e015241. Available from: http://dx.doi.org/10.1136/bmjopen-2016-015241

  44. Barthélémy O, Degrell P, Berman E, Kerneis M, Petroni T, Silvain J, et al. Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis [Internet]. 2015 [cited 2021 Jan 25]; 108(8-9):428-36. Available from: https://doi.org/10.1016/j.acvd.2015.03.002

  45. Pilgrim T, Heg D, Tal K, Erne P, Radovanovic D, Windecker S, et al. Age and Gender-related disparities in primary percutaneous coronary interventions for acute ST-segment elevation myocardial infarction. PLoS One [Internet]. 2015 [cited 2021 Jan 25]; 10(9):e0137047. Available from: https://doi.org/10.1371/journal.pone.0137047

  46. Guelker JE, Bansemir L, Ott R, Kuhr K, Koektuerk B, Turan RG, et al. Gender-based acute outcome in percutaneous coronary intervention of chronic total coronary occlusion. Neth Heart J [Internet]. 2017 [cited 2021 Jan 25]; 25(5):304-11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405030/

  47. Numasawa Y, Kohsaka S, Miyata H, Noma S, Suzuki M, Ishikawa S, et al. Gender differences in in-hospital clinical outcomes after percutaneous coronary interventions: an insight from a japanese multicenter registry. PLoS One [Internet]. 2015 [cited 2021 Jan 25]; 10(1):e0116496. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0116496

  48. Jang JS, Park YA, Jin HY, Seo JS. P4661 Sex difference in mortality among patients with acute myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. European Heart Journal [Internet]. 2017 [cited 2021 Jan 25]; 38(Suppl 1). Available from: https://academic.oup.com/eurheartj/article/38/suppl_1/ehx504.P4661/4090707

  49. Barranco D, Artucio C, Comité de Cardiopatía en la Mujer de la Sociedad Uruguaya de Cardiología, Comité de Hemodinamia de la Sociedad Uruguaya de Cardiología, Perna A, Mayol J. Angioplastia primaria en el infarto agudo de miocardio: diferencias según el género. Subestudio de la casuística uruguaya (2004-2012). Rev. Urug. Cardio [Internet]. 2017 [citado 25 Ene 2021], 32(2):141-9. Disponible en: http://www.scielo.edu.uy/scielo.php?pid=S1688-04202017000200141&script=sci_arttext

  50. Wolff R, Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Sparkes JD, et al. Gender differences in the prevalence and treatment of coronary chronic total occlusions. Catheter CardiovascInterv [Internet]. 2016 [cited 2021 Jan 25]; 87(6):1063-70. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.26330




2020     |     www.medigraphic.com